Related Experiment Video
Updated: May 7, 2025

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
Management of Pediatric Heart Failure
1Hospital for Sick Children, Toronto, Canada. anne.dipchand@sickkids.ca.
Insights
Pediatric heart failure (HF) management requires a multidisciplinary approach, adapting treatments for children and adolescents. Guideline-directed medical therapy, focusing on reverse remodeling, is crucial for improving survival and quality of life in pediatric HF patients.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Medicine
- Pediatric Critical Care
Background:
- Heart failure (HF) in children presents diverse etiologies and clinical courses, impacting survival and quality of life.
- Recognizing HF stages is vital for guiding management and prognosis in pediatric patients.
- Limited evidence exists for pediatric HF therapies, often extrapolated from adult data.
Purpose of the Study:
- To review the current management strategies for systolic heart failure (HF) in children.
- To highlight the importance of guideline-directed medical therapy (GDMT) in pediatric HF.
- To summarize approaches for reverse remodeling in pediatric heart failure.
Main Methods:
- Review of current literature and clinical guidelines for pediatric HF management.
- Focus on guideline-directed medical therapy (GDMT) principles.
- Discussion of multi-disciplinary care and advanced HF therapies.
Main Results:
- Pediatric HF management necessitates a tailored, multi-disciplinary approach.
- Guideline-directed medical therapy (GDMT) is foundational, targeting myocardial reverse remodeling.
- Treatment options range from medications and nutritional support to advanced therapies like transplantation.
Conclusions:
- Effective management of pediatric systolic heart failure requires a comprehensive, adaptive strategy.
- Guideline-directed medical therapy (GDMT) is essential for improving outcomes in children with HF.
- Further research is needed to expand the evidence base for pediatric HF treatments.
Abstract:
Heart failure (HF) in children is a complex syndrome with multiple diverse etiologies and both acute and chronic presentations. Chronic presentations can persist throughout childhood and adolescence, and require diligent management with ongoing reassessment to maximize survival and quality of life. Stages of HF are key to recognize as they guide both management and inform prognosis. In more severe cases, children can present with signs of low cardiac output and circulatory collapse with potential to transition either to a chronic HF stage or progress to a need for advanced HF therapies. Morbidity and mortality are high. Managing HF requires a multi-disciplinary approach that can adapt to the needs of the different phases of childhood and adolescence. Treatment can include medications, nutritional support, activity modifications, and potentially surgical intervention, pacemaker, respiratory or mechanical support, or even heart transplantation. Limited evidence exists for almost all medical therapies used in the management of HF in children and approaches are predominantly extrapolated from extensive adult experience. There are multiple maladaptive pathways in the failing heart; medications that modify these maladaptive pathways promote "reverse remodelling" of the myocardium and are key to the management, forming the basis for "guideline directed medical therapy". The purpose of this review is to summarize the current state of the art management of systolic HF in children.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Diuretics
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Heart Failure Drugs: Inotropic Agents

